1-4 of 4
Andres M Salazar
Close
Sort by
Journal Articles

In Situ Vaccination Improves Efficacy of PD-1 Blockade in Unresponsive Lymphoma Tumors through Induction of a Highly Efficient Cross-Presenting Dendritic Cell Subset Expressing TLR3

Linda Hammerich, Maxime Dhainaut, Tibor Keler, Thomas Davis, MD, Andres M Salazar, Brian D Brown, Joshua Brody, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4106.
https://doi.org/10.1182/blood.V130.Suppl_1.4106.4106
Published: 2017
Journal Articles

WT1 Peptide Vaccine Is Able to Induce WT1-Specifc Immune Response with TCR Clonal Enrichment to Control Minimal Residual Disease in Patients with Myeloid Leukemia

Hongtao Liu, MD PhD, Yuanyuan Zha, PhD, Gregory Malnassy, Noreen Fulton, Margaret Green, Jae-Hyun Park, PhD, Yusuke Nakamura, MD, Richard A. Larson, MD, Andres M Salazar, Olatoyosi Odenike, MD, Thomas Gajewski, MD PhD, Wendy Stock, MD
Journal: Blood
Blood (2016) 128 (22): 3984.
https://doi.org/10.1182/blood.V128.22.3984.3984
Published: 2016
Journal Articles

Combining In Situ Vaccination with Immune Checkpoint Blockade Induces Long-Term Regression of Lymphoma Tumors

Linda Hammerich, PhD, Thomas A. Davis, MD, Tibor Keler, PhD, Andres M Salazar, Joshua Brody, MD
Journal: Blood
Blood (2016) 128 (22): 465.
https://doi.org/10.1182/blood.V128.22.465.465
Published: 2016
Journal Articles

CD141 + dendritic cells produce prominent amounts of IFN-α after dsRNA recognition and can be targeted via DEC-205 in humanized mice

Sonja Meixlsperger, Carol S. Leung, Patrick C. Rämer, Maggi Pack, Liliana D. Vanoaica, Gaëlle Breton, Steve Pascolo, Andres M. Salazar, Andrzej Dzionek, Jürgen Schmitz, Ralph M. Steinman, Christian Münz
Journal: Blood
Blood (2013) 121 (25): 5034–5044.
https://doi.org/10.1182/blood-2012-12-473413
Published: 2013
Includes: Supplemental data